Related references
Note: Only part of the references are listed.Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma: Carcinogenesis of Perihilar Type and Aggressive Behavior of Peripheral Type
Shinichi Aishima et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma
Shin Hamada et al.
CANCER SCIENCE (2011)
Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression
Tsan-Hua Yu et al.
MODERN PATHOLOGY (2011)
Calcium, troponin, calmodulin, S100 proteins: From myocardial basics to new therapeutic strategies
Marcus C. Schaub et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Proposal of progression model for intrahepatic cholangiocarcinoma: Clinicopathologic differences between hilar type and peripheral type
Shinichi Aishima et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients
GZ Wang et al.
CANCER RESEARCH (2006)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: Preliminary report based on interobserver agreement
Y Zen et al.
PATHOLOGY INTERNATIONAL (2005)
Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid
K Birkenkamp-Demtroder et al.
GUT (2005)
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer
A Hammacher et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer
SE Dowen et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)
T Arumugam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer
S Diederichs et al.
CANCER RESEARCH (2004)
Ca2+-dependent binding and activation of dormant ezrin by dimeric, S100P
M Koltzscher et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology
K Okuda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Worldwide trends in mortality from biliary tract malignancies
T Patel
BMC CANCER (2002)
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
TC Chen et al.
HEPATOLOGY (2001)
Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma
A Bergquist et al.
JOURNAL OF INTERNAL MEDICINE (2001)
Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver
A Tannapfel et al.
GUT (2000)